Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 10/31/2025 | 179,827,919 | Total gross of voting rights: 179,827,919 |
Total net* of voting rights: 179,741,847 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$13.24 |
| Daily Change: | 0.18 1.38 |
| Daily Volume: | 14,323 |
| Market Cap: | US$475.980M |
November 11, 2025 October 28, 2025 October 06, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
